Literature DB >> 33537244

Herpes Simplex Virus Cell Entry Mechanisms: An Update.

Krishnaraju Madavaraju1, Raghuram Koganti1, Ipsita Volety1, Tejabhiram Yadavalli1, Deepak Shukla1,2.   

Abstract

Herpes simplex virus (HSV) can infect a broad host range and cause mild to life threating infections in humans. The surface glycoproteins of HSV are evolutionarily conserved and show an extraordinary ability to bind more than one receptor on the host cell surface. Following attachment, the virus fuses its lipid envelope with the host cell membrane and releases its nucleocapsid along with tegument proteins into the cytosol. With the help of tegument proteins and host cell factors, the nucleocapsid is then docked into the nuclear pore. The viral double stranded DNA is then released into the host cell's nucleus. Released viral DNA either replicates rapidly (more commonly in non-neuronal cells) or stays latent inside the nucleus (in sensory neurons). The fusion of the viral envelope with host cell membrane is a key step. Blocking this step can prevent entry of HSV into the host cell and the subsequent interactions that ultimately lead to production of viral progeny and cell death or latency. In this review, we have discussed viral entry mechanisms including the pH-independent as well as pH-dependent endocytic entry, cell to cell spread of HSV and use of viral glycoproteins as an antiviral target.
Copyright © 2021 Madavaraju, Koganti, Volety, Yadavalli and Shukla.

Entities:  

Keywords:  HSV; endocytosis; entry; herpesvirus; mechanism

Year:  2021        PMID: 33537244      PMCID: PMC7848091          DOI: 10.3389/fcimb.2020.617578

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  198 in total

1.  Capturing the herpes simplex virus core fusion complex (gB-gH/gL) in an acidic environment.

Authors:  Tina M Cairns; J Charles Whitbeck; Huan Lou; Ekaterina E Heldwein; Tirumala K Chowdary; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

2.  Substitution of herpes simplex virus 1 entry glycoproteins with those of saimiriine herpesvirus 1 reveals a gD-gH/gL functional interaction and a region within the gD profusion domain that is critical for fusion.

Authors:  Qing Fan; Richard Longnecker; Sarah A Connolly
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

3.  {alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2.

Authors:  Tatiana Gianni; Valentina Gatta; Gabriella Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

Review 4.  The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells.

Authors:  G Campadelli-Fiume; F Cocchi; L Menotti; M Lopez
Journal:  Rev Med Virol       Date:  2000 Sep-Oct       Impact factor: 6.989

5.  Nonsulfated, cinnamic acid-based lignins are potent antagonists of HSV-1 entry into cells.

Authors:  Jay N Thakkar; Vaibhav Tiwari; Umesh R Desai
Journal:  Biomacromolecules       Date:  2010-05-10       Impact factor: 6.988

Review 6.  Peptide inhibitors against herpes simplex virus infections.

Authors:  Stefania Galdiero; Annarita Falanga; Rossella Tarallo; Luigi Russo; Emilia Galdiero; Marco Cantisani; Giancarlo Morelli; Massimiliano Galdiero
Journal:  J Pept Sci       Date:  2013-02-07       Impact factor: 1.905

7.  A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection.

Authors:  Lesia K Dropulic; Makinna C Oestreich; Harlan L Pietz; Kerry J Laing; Sally Hunsberger; Keith Lumbard; Doreen Garabedian; Siu Ping Turk; Aiying Chen; Ronald L Hornung; Chetan Seshadri; Malisa T Smith; Nancy A Hosken; Sanjay Phogat; Lee-Jah Chang; David M Koelle; Kening Wang; Jeffrey I Cohen
Journal:  J Infect Dis       Date:  2019-08-09       Impact factor: 5.226

8.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Interaction between nectin-1 and the human natural killer cell receptor CD96.

Authors:  Veronica M Holmes; Carlos Maluquer de Motes; Paige T Richards; Jessenia Roldan; Arjun K Bhargava; Jordan S Orange; Claude Krummenacher
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

10.  Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B.

Authors:  Tzviya Zeev-Ben-Mordehai; Daven Vasishtan; Anna Hernández Durán; Benjamin Vollmer; Paul White; Arun Prasad Pandurangan; C Alistair Siebert; Maya Topf; Kay Grünewald
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-24       Impact factor: 11.205

View more
  20 in total

1.  Screening of candidate genes associated with high titer production of oncolytic measles virus based on systems biology approach.

Authors:  Malihe Rastegarpanah; Kayhan Azadmanesh; Babak Negahdari; Yazdan Asgari; Mohammadali Mazloomi
Journal:  Virus Genes       Date:  2022-04-27       Impact factor: 2.332

2.  CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms.

Authors:  Emmanuel Cohen; Jammy Mariotton; Flore Rozenberg; Anette Sams; Toin H van Kuppevelt; Nicolas Barry Delongchamps; Marc Zerbib; Morgane Bomsel; Yonatan Ganor
Journal:  Mucosal Immunol       Date:  2022-05-13       Impact factor: 8.701

3.  The Inhibition of DNA Viruses by the Amphibian Antimicrobial Peptide Temporin G: A Virological Study Addressing HSV-1 and JPCyV.

Authors:  Maria Elena Marcocci; Bianka Gabriela Jackowska; Carla Prezioso; Virginia Protto; Marta De Angelis; Francesco Saverio Di Leva; Bruno Casciaro; Alfonso Carotenuto; Maria Luisa Mangoni; Anna Teresa Palamara; Valeria Pietropaolo; Giovanna De Chiara; Lucia Nencioni
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

4.  Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases.

Authors:  Shu Shen; Yaxian Zhang; Zhiyun Yin; Qiong Zhu; Jingyuan Zhang; Tiantian Wang; Yaohui Fang; Xiaoli Wu; Yuan Bai; Shiyu Dai; Xijia Liu; Jiayin Jin; Shuang Tang; Jia Liu; Manli Wang; Yu Guo; Fei Deng
Journal:  BMC Med       Date:  2022-10-21       Impact factor: 11.150

5.  Characterization of Host Cell Potential Proteins Interacting with OsHV-1 Membrane Proteins.

Authors:  Jiangnan Yu; Ying Liu; Bowen Huang; Chen Li; Dandan Wang; Mengli Yao; Lusheng Xin; Changming Bai; Chongming Wang
Journal:  Viruses       Date:  2021-12-15       Impact factor: 5.048

6.  Characterization of Ictalurid herpesvirus 1 Glycoprotein ORF59 and Its Potential Role on Virus Entry into the Host Cells.

Authors:  Shu-Xin Li; Fei Yu; Hong-Xun Chen; Xiao-Dong Zhang; Li-Hui Meng; Kai Hao; Zhe Zhao
Journal:  Viruses       Date:  2021-11-29       Impact factor: 5.048

7.  The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.

Authors:  M D Maldonado; J Romero-Aibar
Journal:  Brain Behav Immun Health       Date:  2021-10-30

Review 8.  Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides.

Authors:  Špela Gruden; Nataša Poklar Ulrih
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

9.  Synthesis and Evaluation of Some Uracil Nucleosides as Promising Anti-Herpes Simplex Virus 1 Agents.

Authors:  Samir Mohamed Awad; Shima Mahmoud Ali; Yara Essam Mansour; Samar Said Fatahala
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

Review 10.  Two Sides to Every Story: Herpes Simplex Type-1 Viral Glycoproteins gB, gD, gH/gL, gK, and Cellular Receptors Function as Key Players in Membrane Fusion.

Authors:  Nithya Jambunathan; Carolyn M Clark; Farhana Musarrat; Vladimir N Chouljenko; Jared Rudd; Konstantin G Kousoulas
Journal:  Viruses       Date:  2021-09-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.